Related Experiment Videos
[Side-effects and doping control of anabolic steroids]
1Arbejdsmedicinsk afdeling, Roskilde Amts Sygehus Køge.
Ugeskrift for Laeger
|October 3, 1994
Summary
Anabolic steroid use, specifically trenbolone and stanozolol, can elevate cardiac enzyme levels. These levels normalized after discontinuing steroid use, highlighting potential cardiac risks for bodybuilders.
Area of Science:
- Sports Medicine
- Cardiology
- Toxicology
Background:
- Anabolic steroids (AS) are frequently misused by athletes for performance enhancement.
- Understanding the potential adverse effects of AS on cardiac health is crucial.
Observation:
- A 26-year-old male bodybuilder reported 10 weeks of trenbolone and stanozolol use.
- Elevated creatine-kinase (CK) and cardiac-specific CK-B isoenzyme levels were observed after 4 weeks.
- The individual remained asymptomatic with normal electrocardiography.
Findings:
- CK and CK-B levels normalized within 3 weeks of AS cessation.
- Stanozolol was undetectable by doping control, suggesting rapid excretion.
- This case highlights a potential link between specific AS and cardiac enzyme elevation.
Implications:
- Bodybuilders and athletes using AS face potential cardiac risks.
- Increased awareness and education regarding AS toxicity are necessary.
- Further research into the cardiac effects of specific AS, like stanozolol, is warranted.